The Latest in GI and Hepatology News

FDA Emphasizes Alternative Device Sterilization Strategies

February 13, 2024

Mood Interventions May Reduce IBD Inflammation

February 13, 2024

IBD & Intestinal Disorders

FDA OKs First Oral Agent for Eosinophilic Esophagitis

February 13, 2024

Upper GI Tract

Biosimilars Have Driven Down Cost of Infliximab

February 12, 2024

IBD & Intestinal Disorders

NEJM Study Highlights Resmetirom’s Efficacy in NASH With Liver Fibrosis

February 9, 2024

Liver Disease

In Refractory IBD, Combination Therapies Appear Safe, Effective

February 8, 2024

IBD & Intestinal Disorders

Automated ADR Software Shows Promise

February 7, 2024

Endoscopy

Meta-Analysis Highlights Litany of MASLD-Associated Complications, Encouraging New Treatment Targets

February 7, 2024

Liver Disease

AGA Gives Guidance on Subepithelial Lesions

February 7, 2024

Telephone Best for Switching Patients to New Colonoscopy Intervals

February 6, 2024

Gastric cancer screening benefits may vary by country

February 6, 2024

BCBSMA Rolls Back Restrictive Anesthesia Policy

February 6, 2024

Dueling Gut Bacteria Impact Chronic HBV Progression

February 6, 2024

Liver Disease

AGA updates polypectomy guidance

February 5, 2024

Iron Overload in Non-HFE Liver Disease: Not all Iron is Ready to Strike

February 5, 2024

Liver Disease